Search
Now showing items 1-4 of 4
Which Definition Should be used to Determine Colchicine Resistance Among Patients with Familial Mediterranean Fever?
(Clin Exp Rheumatol, 2018-11-12)
Objectives: Colchicine is the main therapy for familial Mediterranean fever (FMF); however, 5-10% of patients are colchicine-resistant. There is no standard and validated definition for colchicine resistance. We aimed to ...
Two cases of glutaric aciduria type II: how to differentiate from inflammatory myopathies?
(Taylor and Francis, 2018-11-19)
Muscle weakness is a nonspecific finding of myopathy of any etiology that include iatrogenic, toxic, endocrinological, infectious, immunologic, and metabolic disorders. Among the metabolic myopathies glutaric aciduria type ...
Some concerns from Turkey
(BMJ, 2018-11-24)
We read the paper written by Kaneko et al with great interest.1 This study demonstrates the safety and efficacy of tocilizumab in patients with adult-onset Still’s disease (AOSD). This randomised placebo-controlled study ...
Polyarteritis nodosa: lessons from 25 years of experience
(Clin Exp Rheumatol, 2018-10-30)
Objectives: Polyarteritis nodosa is a necrotising vasculitis of predominantly medium size vessels. The present study aimed to summarise the characteristics of PAN patients, and also analyse the trend of decreasing PAN ...